Intracranial Aneurysm Market Size & Growth Forecast 2027–2036, By Segments (End-use, Treatment Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Intracranial Aneurysm Market size was worth USD 1.75 Billion in 2026 and is expected to grow at 9.65% CAGR between 2027 and 2036, crossing USD 4.4 Billion by 2036. The industry revenue for 2027 is calculated at USD 1.89 Billion.
Get more details on this report
Request Free Sample ReportIntracranial Aneurysm Market Intelligence Snapshot
Regional Market Dynamics
- North America held 44.2% in 2026, supported by advanced neurological infrastructure, specialist expertise, sophisticated technologies, and strong access to diagnostic and treatment capabilities.
- Asia Pacific is expected to grow fastest as healthcare infrastructure, specialized hospitals, physician training, investment, and access to advanced neurovascular procedures continue expanding.
Segment Momentum
- Hospitals held a 62.4% market share in 2026 because they provide specialized expertise, advanced imaging, surgical technologies, and comprehensive care required for complex intracranial aneurysm diagnosis and treatment.
- Flow diverters are gaining adoption for treating complex and wide-neck aneurysms, supported by improving device designs, growing clinical acceptance, and demand for advanced endovascular treatment options.
Market Expansion Drivers
- Rising hypertension and lifestyle disorders increasing intracranial aneurysm incidence globally
- Expanding neurointerventional procedures and specialist availability improving treatment access
- Advancements in minimally invasive endovascular devices enhancing procedural success rates
Leading Market Participants
- Leading players in the intracranial aneurysm market include Medtronic plc (Ireland), Stryker Corporation (USA), Johnson & Johnson (USA), Terumo Corporation (Japan), Penumbra, Inc. (USA), MicroPort Scientific Corporation (China), B. Braun Melsungen AG (Germany), Balt Extrusion S.A. (France), Integra LifeSciences Holdings Corporation (USA), Wallaby Medical (China)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.75 Billion
- 2027 Estimated Market Size: USD 1.89 Billion
- Projected Market Size: USD 4.4 Billion by 2036
- Growth Forecast: 9.65% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End-use) | Endovascular Coiling (Treatment Type)
- Emerging Opportunity Segment: Clinics (End-use) | Flow Diverters (Treatment Type)
Market Growth Drivers and Industry Trends
Rising hypertension and lifestyle disorders increasing intracranial aneurysm incidence globally
The increasing prevalence of hypertension, obesity, smoking, and other lifestyle-related risk factors is contributing to a growing number of individuals susceptible to cerebrovascular disorders. The intracranial aneurysm market growth is driven by the rising clinical burden associated with aneurysm formation and rupture, leading to greater demand for early diagnosis, continuous monitoring, and timely therapeutic intervention. Healthcare providers are placing greater emphasis on identifying high-risk patients through advanced neurological assessment and imaging to reduce the likelihood of life-threatening complications.
Expanding neurointerventional procedures and specialist availability improving treatment access
Healthcare systems are strengthening neurovascular care by expanding specialized treatment centers and increasing the availability of trained neurointerventional professionals. As access to these services improves, the intracranial aneurysm market will experience higher procedure volumes through broader adoption of catheter-based interventions and comprehensive stroke care pathways. Improved referral networks and multidisciplinary treatment approaches are enabling patients to receive specialized care more efficiently across both emergency and elective clinical settings.
Advancements in minimally invasive endovascular devices enhancing procedural success rates
Continuous innovation in endovascular technologies is improving the precision and effectiveness of aneurysm treatment while reducing the need for highly invasive surgical procedures. The intracranial aneurysm market will benefit from advancements in devices such as flow diverters, embolization coils, and intracranial stents that enable clinicians to treat complex aneurysms with greater procedural control and enhanced safety. These innovations support shorter recovery periods, lower procedural risks, and improved treatment outcomes across a broader range of patient populations.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising hypertension and lifestyle disorders increasing intracranial aneurysm incidence globally | 2% | High | North America, Europe | High | Near Term |
| Expanding neurointerventional procedures and specialist availability improving treatment access | 1.7% | High | North America, Asia Pacific | High | Mid Term |
| Advancements in minimally invasive endovascular devices enhancing procedural success rates | 1.8% | High | Europe, North America | High | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the intracranial aneurysm market, accounting for 44.2% in 2026, supported by advanced neurological care infrastructure, high awareness of cerebrovascular disorders, and broad access to sophisticated diagnostic and treatment technologies. The region has well-developed specialist healthcare networks capable of managing complex aneurysm cases through minimally invasive and surgical interventions. Continued advances in neurovascular imaging, endovascular treatment approaches, and clinical capabilities are improving diagnosis and treatment options. Increasing attention to early detection of cerebrovascular conditions and the availability of specialized medical expertise are also contributing to sustained demand for intracranial aneurysm diagnosis and treatment.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to experience the fastest growth, driven by improving healthcare infrastructure, rising awareness of neurological disorders, and expanding access to advanced neurovascular procedures. Growing healthcare investment and the development of specialized hospitals are increasing the availability of diagnostic imaging and minimally invasive treatment options. An aging population, changing lifestyle patterns, and greater recognition of cerebrovascular diseases are also contributing to demand for earlier diagnosis and intervention. In addition, improvements in physician training and access to advanced medical technologies are expected to support broader adoption of intracranial aneurysm treatment solutions throughout the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Advanced NeurointerventionThe U.S. continues expanding access to minimally invasive intracranial aneurysm treatment through advanced neurovascular centers. Hospitals are adopting innovative embolization technologies while strengthening early diagnosis and multidisciplinary care pathways for complex cases.
Germany 🇩🇪
Precision Treatment AdoptionGermany emphasizes evidence-based intracranial aneurysm management supported by specialized neurosurgical and interventional radiology expertise. Healthcare providers are adopting advanced imaging and minimally invasive treatment options to improve procedural planning and patient outcomes.
Japan 🇯🇵
Early Detection StrategyJapan places strong emphasis on identifying intracranial aneurysms through advanced diagnostic imaging and routine neurological evaluation. Medical centers continue refining minimally invasive interventions while supporting treatment decisions with detailed vascular assessment.
South Korea 🇰🇷
Neurovascular InnovationSouth Korea is investing in advanced neurovascular technologies that improve intracranial aneurysm diagnosis and catheter-based treatment. Hospitals are integrating sophisticated imaging platforms with specialized clinical expertise to enhance procedural precision.
France 🇫🇷
Coordinated Stroke CareFrance integrates intracranial aneurysm management within comprehensive neurovascular care networks to improve timely intervention. Clinical priorities include minimally invasive treatment availability, standardized care pathways, and expanded use of advanced vascular imaging.
Italy 🇮🇹
Specialized Clinical NetworksItaly is strengthening specialized neurological centers to improve access to intracranial aneurysm diagnosis and intervention. Healthcare providers are expanding endovascular treatment capabilities while enhancing collaboration between neurosurgical and imaging specialists.
Segment Leadership and Growth Trends
Intracranial Aneurysm Market Share (%), End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals (Largest Segment) vs Clinics (Fastest-Growing Segment)
In the intracranial aneurysm market, hospitals segment dominated the market, accounting for the largest share of 62.4% in 2026. Hospitals serve as the primary centers for diagnosing and treating complex neurological conditions due to their advanced infrastructure, availability of specialized medical professionals, and access to sophisticated imaging and surgical technologies. The management of intracranial aneurysms often requires multidisciplinary care, including neurosurgical interventions, endovascular procedures, and post-treatment monitoring, which strengthens the role of hospitals in this segment. The growing preference for comprehensive treatment facilities capable of handling critical cases continues to support the strong position of hospitals in the market.
The clinics segment is expected to witness significant growth during the forecast period, driven by increasing demand for accessible and specialized neurological care. Clinics are gaining importance as outpatient diagnosis and follow-up care become more widely adopted for patients requiring continuous monitoring and early intervention. The expansion of specialized clinics offering focused aneurysm evaluation and minimally invasive treatment support is contributing to the rising adoption of these healthcare settings. Additionally, improvements in diagnostic capabilities are enabling clinics to manage a broader range of patient needs, supporting their faster growth within the end-use segment.
Treatment Type Segment Analysis: Endovascular Coiling (Largest Segment) vs Flow Diverters (Fastest-Growing Segment)
The intracranial aneurysm market was led by the endovascular coiling segment, which captured the largest share of 64.03% in 2026. Endovascular coiling is widely preferred due to its minimally invasive nature, effectiveness in treating various aneurysm types, and ability to reduce the need for open surgical procedures. The technique allows physicians to treat aneurysms through catheter-based approaches, resulting in shorter recovery periods and improved patient outcomes compared with traditional surgical methods. Continuous advancements in coil technology and increasing preference for less invasive neurological interventions are reinforcing the adoption of endovascular coiling procedures.
The flow diverters segment is projected to experience notable growth owing to their increasing application in the treatment of complex and wide-neck intracranial aneurysms. These devices provide an alternative approach by redirecting blood flow away from the aneurysm while supporting vessel healing. Growing clinical acceptance of advanced endovascular solutions, along with improvements in device design and procedural outcomes, is encouraging greater adoption of flow diverters among healthcare providers. The expanding focus on treating challenging aneurysm cases with innovative technologies is expected to support the segment’s rapid development.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Clinics, Others | Hospitals | Clinics |
| Treatment Type | Endovascular Coiling, Surgical Clipping, Flow Diverters, Others | Endovascular Coiling | Flow Diverters |
Competitive Landscape and Market Positioning
Major players in the intracranial aneurysm market:
- Medtronic plc (Ireland)
- Stryker Corporation (USA)
- Johnson & Johnson (USA)
- Terumo Corporation (Japan)
- Penumbra, Inc. (USA)
- MicroPort Scientific Corporation (China)
- B. Braun Melsungen AG (Germany)
- Balt Extrusion S.A. (France)
- Integra LifeSciences Holdings Corporation (USA)
- Wallaby Medical (China)
Advancements in minimally invasive treatment approaches are reshaping competition within the intracranial aneurysm market as providers focus on improving procedural precision, patient outcomes, and physician adoption. Companies are increasingly differentiating through innovations that address complex aneurysm cases, enhance treatment reliability, and support broader clinical usability rather than competing solely on established intervention methods. The competitive environment is further influenced by growing demand for specialized devices and techniques that can balance effectiveness with reduced procedural burden, creating pressure for continuous refinement of therapeutic solutions.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Stryker Corporation (USA) | |||||||
| Johnson & Johnson (USA) | |||||||
| Terumo Corporation (Japan) | |||||||
| Penumbra Inc. (USA) | |||||||
| MicroPort Scientific Corporation (China) | |||||||
| B. Braun Melsungen AG (Germany) | |||||||
| Balt Extrusion S.A. (France) | |||||||
| Integra LifeSciences Holdings Corporation (USA) | |||||||
| Wallaby Medical (China) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Kaneka Corporation | Oct-25 | Kaneka Corporation commenced European sales of its i-ED brain aneurysm embolization coil, following EC certification under the EU Medical Device Regulation in July 2025. Featuring specialized wire thickness and structural engineering, the device is designed to improve packing density and conformability in irregularly shaped aneurysms, supporting the company's global expansion strategy within the neurovascular intervention segment. |
| Penumbra | Sep-25 | Penumbra received CE mark approval for its SwiftPAC neuroembolisation coil, enabling commercial availability across Europe. The soft, space-seeking coil expands the company's Swift coil system portfolio and supports the endovascular treatment of intracranial aneurysms through enhanced conformability and dense embolisation capabilities. |
| Nova Neuro | Aug-25 | Nova Neuro partnered with Prima Mente and University at Buffalo Neurosurgery in a multidisciplinary initiative awarded a US$144,500 grant to develop an AI- and multiomics-based tool for predicting intracranial aneurysm rupture risk. This project aims to advance clinical decision support systems for aneurysm management, potentially improving risk assessment and patient-specific treatment strategies. |
| Medtronic | Jun-24 | Medtronic commercially launched its Artisse aneurysm embolisation system in Europe. This next-generation intrasaccular treatment platform is designed to improve treatment personalization by providing enhanced conformability, softness, and procedural simplicity, addressing clinical requirements for effective intracranial aneurysm care. |
| Cerenovus, Inc. | May-23 | Cerenovus, a Johnson & Johnson company, announced the U.S. commercial availability of its Cerepak detachable coils. The system, which features multiple shapes and sizes to assist in concentric aneurysm filling, was introduced to expand the company’s hemorrhagic stroke portfolio and provide physicians with advanced tools for endovascular embolization. |
| MicroPort | Aug-22 | MicroPort NeuroTech received marketing approval from Japan's Ministry of Health, Labour and Welfare for its Numen Coil Embolization System. As the company’s first product approved in the Japanese market, this milestone validated the device’s innovative clinical design and performance, strengthening MicroPort’s international market presence and neurovascular technology footprint. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Intracranial Aneurysm Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Aneurysm Location | Anterior Communicating Artery, Internal Carotid Artery, Middle Cerebral Artery, Posterior Communicating Artery, Vertebrobasilar Arteries, Other Locations |
| Rupture Status | Ruptured Aneurysms, Unruptured Aneurysms |
| Aneurysm Size | Small Aneurysms, Medium Aneurysms, Large Aneurysms, Giant Aneurysms |
Intracranial Aneurysm Market — report.custom
| Custom Chapter | Custom Details |
|---|---|
| Patient Diagnosis-to-Treatment Pathways |
|
| Clinical Adoption & Physician Decision Drivers |
|
| Unmet Needs in Aneurysm Management |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the intracranial aneurysm market?
How is the intracranial aneurysm industry size expected to evolve during the forecast period?
How are advances in neurovascular care improving access to intracranial aneurysm treatment?
Why are minimally invasive endovascular technologies accelerating adoption in the intracranial aneurysm market?
Why do hospitals account for the largest share of the intracranial aneurysm market?
Why are flow diverters the fastest-growing treatment segment in the intracranial aneurysm market?
Why does North America lead the intracranial aneurysm market?
How is Asia Pacific positioned for growth in the intracranial aneurysm market?
Which companies are driving growth in the intracranial aneurysm landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization